LIVER-DISTRIBUTED FXR AGONIST TERN-101 DEMONSTRATES FAVORABLE SAFETY AND EFFICACY PROFILE IN NASH PHASE 2a LIFT STUDYRohit Loomba,Kris V. Kowdley,Raj Vuppalanchi,Tarek Hassanein, Sergio E. Rojter,Muhammad Y. Sheikh,Sam Moussa,Diana Chung,Clarence Eng,Tonya Marmon, Mona Qureshi,Erin Quirk,Daria Crittenden,Eric J. LawitzHEPATOLOGY(2021)引用 2|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要